GlaxoSmithKline PLC ADR (GSK) is a Healthcare · Drug Manufacturers - General company listed on NYSE. Price $50.22 (-1.65%), Market cap $101.38B, P/E ratio 13.08, 52-week low–high $36.20 ~ $61.18.
GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through Commercial Operations and Total R&D segments. The company offers specialty medicines that include oncology, respiratory/immunology, inflammation, and inhaled medicines for HIV, respiratory eosinophildriven diseases, lupus and lupus nephritis, ovarian cancer, and endometrial cancer. It also provides vaccines for Shingles, Meningitis, RSV, Seasonal Influenza, Hepatitis, Diphtheria, Tetanus, Acellular Pertussis, Rotavirus, Pertussis, Po
Financial statements, price targets, institutional (13F) holdings and related news for GlaxoSmithKline PLC ADR are updated in real time on BlackAll Trade.
GlaxoSmithKline PLC ADR trades at $50.22 (-1.65%). Real-time quotes and charts are available on BlackAll Trade.
GlaxoSmithKline PLC ADR has a market cap of about $101.38B. Its P/E ratio is 13.08.
GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdo